HemaSphere
(Jun 2022)
P1275: PERCENTAGE OF TUMOR INFILTRATING T LYMPHOCYTES MEASURED BY FLOW CYTOMETRY AT DIAGNOSIS PREDICTS SURVIVAL AFTER SALVAGE CHEMOTHERAPY IN RELAPSED/ REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA PATIENTS.
L. Korin,
M. Fuente,
S. Cranco,
A. Vitriu,
P. Ochoa,
E. Babuin,
O. Gelo,
L. Ayala,
P. Tempra,
M. Venegas,
A. Novoa,
A. Vijnovich,
N. Tartas,
M. D. R. Custidiano,
M. C. Foncuberta,
J. Sanchez Avalos
Affiliations
L. Korin
1 Hematology
M. Fuente
1 Hematology
S. Cranco
1 Hematology
A. Vitriu
1 Hematology
P. Ochoa
1 Hematology
E. Babuin
1 Hematology
O. Gelo
1 Hematology
L. Ayala
1 Hematology
P. Tempra
2 flow cytometry, Instituto Alexander Fleming
M. Venegas
2 flow cytometry, Instituto Alexander Fleming
A. Novoa
2 flow cytometry, Instituto Alexander Fleming
A. Vijnovich
3 Pathology, Cepacit, Buenos Aires, Argentina
N. Tartas
1 Hematology
M. D. R. Custidiano
1 Hematology
M. C. Foncuberta
1 Hematology
J. Sanchez Avalos
1 Hematology
DOI
https://doi.org/10.1097/01.HS9.0000847964.45968.60
Journal volume & issue
Vol. 6
pp.
1160
– 1161
WeChat QR code
Close